Heterotrimeric GTP-binding proteins (G proteins) transduce extracellular signals into intracellular signals by activating effector molecules including adenylate cyclases that catalyze cAMP formation, and thus regulate various cellular responses such as metabolism, proliferation, and apoptosis. cAMP signaling pathways have been reported to protect cells from ionizing radiation-induced apoptosis, but however, the protective mechanism is not clear. Therefore, this study aimed to investigate the signaling molecules and the mechanism mediating the anti-apoptotic action of cAMP signaling system in radiation-induced apoptosis. Stable expression of a constitutively active mutant of Gα s (Gα sQL) protected gamma ray-induced apoptosis which was assessed by analysis of the cleavages of PARP, caspase-9, and caspase-3 and cytochrome C release in SH-SY5Y human neuroblastoma cells. GαsQL repressed the gamma ray-induced down-regulation of Bcl-xL protein, but transfection of Bcl-xL siRNA increased the gamma ray-induced apoptosis and abolished the anti-apoptotic effect of Gα sQL. Gα sQL decreased the degradation rate of Bcl-xL protein, and it also restrained the decrease in Bcl-xL mRNA by increasing the stability following ionizing irradiation. Furthermore, prostaglandin E2 that activates Gαs was found to protect gamma ray-induced apoptosis, and the protective effect was abolished by treatment with prostanoid receptor antagonist specific to EP2/4R subtype. Moreover, specific agonists for adenosine A1 receptor that inhibits cAMP signaling pathway augmented gamma ray-induced apoptosis. From this study, it is concluded that Gαs-cAMP signaling system can protect SH-SY5Y cells from gamma ray-induced apoptosis partly by restraining down-regulation of Bcl-xL expression, suggesting that radiation-induced apoptosis can be modulated by GPCR ligands to improve the efficiency of radiation therapy.
Introduction
The heterotrimeric GTP-binding proteins (G proteins) are composed of α , β and γ subunits, and are classified, based on the primary sequences of α subunit of G protein (Gα ) subunits, into four main families: Gα s, Gα i, Gα q, and Gα 12. A wide range of external stimuli, including neurotransmitters, growth factors, hormones, light, odorants, and certain taste ligands, can activate specific members of G proteins-coupled receptor (GPCR) family, which induce a conformational change of the coupled G protein to cause exchange of GDP with GTP in the α subunit, and thus dissociation of α and βγ heterodimer (Gβγ) (Neer, 1995) . The GTP-bound Gα and Gβγ regulate a wide variety of intracellular signaling pathways including adenylate cyclases, phospholipases, phosphodiesterases, and ion channels to transduce extracellular signals into intracellular signals (Gilman, 1987) . The Gα -bound GTP is hydrolyzed to GDP by intrinsic GTPase, a process that is regulated by RGS (regulator of G-protein signaling), which leads to reassociation of the Gαβγ heterotrimer and termination of the activation cycle (McCudden et al., 2005) .
Radiation therapy, together with surgery and chemotherapy, forms the major treatment modality for various cancers, and it can be used alone or together with chemotherapy to produce cure of localized tumors and control of the primary site of tumors that have disseminated. Ionizing radiation induces cancer cell death via various mechanisms including apoptosis. However, development of radioresistance of tumor cells results in unsuccessful treatment, and thus understanding the mechanisms for cell death and development of radioresistance is essential for improving the efficiency of radiotherapy for cancer. Ionizing radiation has been shown to regulate expression and activity of various molecules involved in cell death including Bcl-2 family proteins in a variety of cancer cell lines (Findley et al., 1997) . Bcl-2 family proteins are classified according to their effects on cellular apoptosis, as anti-apoptotic proteins and pro-apoptotic proteins. The anti-apoptotic members include Bcl-2, Bcl-xL, Bfl-1, Bcl-W, and Mcl-1, and the pro-apoptotic members include Bax, Bak, and Bik. Ionizing radiation induces an increase in Bax expression, and the activated Bax/Bak induces apoptosis by allowing outer mitochondrial membrane permeabilization and release of cytochrome C which leads to activation of caspase-9 and caspase-3 (Morrison et al., 2005) . Ionizing radiation also induces a decrease in Bcl-2 and Bcl-xL, which can inhibit the apoptosis induced by various cytotoxic drugs (Huang et al., 1997) .
Apoptosis is regulated by various cellular signaling systems including cAMP signaling pathway. Production of cAMP from ATP is catalyzed by adenylate cyclases, which are activated by stimulatory G proteins (Gs) but inhibited by inhibitory G proteins (Gi). cAMP binds and activates cAMPdependent protein kinase (PKA), which phosphorylates various target proteins that contribute to regulation of a variety of cellular responses including apoptosis (Koyama et al., 2001) . Increased cAMP levels were reported to exert protective effects against radiation-induced apoptosis (Lehnert, 1975) , and the Gα s-mediated signaling also protected reactive oxygen species induced apoptosis (Lewerenz et al., 2003) . Inhibition of PKA enhanced the cytotoxic effects of ionizing radiation in radioresistant cells by inhibiting prosurvival signaling molecules such as Bcl-2 (Tortora and Ciardiello, 2002; Chin et al., 2005) .
However, the underlying molecular mechanism of the protective effect of Gα s-cAMP signaling pathways against ionizing radiation-induced apoptosis is not clearly known. Thus, we aimed to investigate the molecular mechanism for Gαs-cAMP signaling pathways to inhibit radiationinduced apoptosis in this study, and found that Gα s inhibits gamma ray-induced apoptosis by restraining Bcl-xL down-regulation in SH-SY5Y human neuroblastoma cells.
Materials and Methods

Cell culture and reagents
SH-SY5Y human neuroblastoma cells were purchased from the American Type Culture Collection (ATCC, Manassas, VA), and maintained in DMEM containing 10% FBS (JBI, Korea) and 100 U/ml penicillin/streptomycin, in a 5% CO2 incubator at 37 o C. SH-SY5Y cells stably expressing constitutively active mutant Gαs (GαsQ227L) were established in previous study (Jang and Juhnn, 2001) . N-acetyl-L-cysteine (NAC), actinomycin D, AH-6809, AH23848, 2-chloro-N(6)-cyclopentyladenosine (CCPA), cycloheximide, DMSO, prostaglandin E2 (PGE2), R-phenylisopropyl-adenosine (R-PIA) and SC19220 were purchased from Sigma (St. Louise, MO).
Measurement of cAMP accumulation
cAMP levels were determined by competitive binding with [3H]cAMP to a cAMP binding protein, the regulatory subunit RIα of cAMP dependent protein kinase which was expressed in E. coli. In brief, the culture medium was removed from a 12-well plate containing the SH-SY5Y neuroblastoma cells, and cAMP was extracted by immediate addition of 2.5 M perchloric acid. After the acid extract was neutralized with 4.2 M KOH, cAMP levels were determined by competitive binding with [3H] cAMP to the cAMP binding protein, and cAMP levels were normalized to the amount of acidinsoluble protein.
Irradiation with gamma ray
Cells were plated in 10-cm dishes and incubated until 80% confluent. Cells were then exposed to gamma-rays from a 137 Cs source at a delivering dose rate of 246.5 cGy/min.
Cell viability assay
Cells (5,000 cells/well in 96-well plates, 100 µl) were exposed to 0-30 Gy of gamma ray. After 24 h, cells were incubated with 0.5 mg/ml MTT for 2 h. Absorption at 595 nm was measured after solubilization of the formazan crystals with DMSO. Assays were performed in triplicate, and mean cell viability was compared to DMSO-treated controls.
Flow cytometric analysis of Annexin V stained cells
Apoptosis was quantified using Annexin V-FITC apoptosis kits (BD Biosciences, San Diego, CA) according to the manufacturer's instructions. Construction and transfection of Bcl-xL small interference RNA (siRNA) Double strand DNA coding Bcl-xL siRNA was prepared by annealing the chemically synthesized oligonucleotides having complementary sequences; a forward primer 5'-CACCGCAGGGACAGCA-TATCAGAGCGAACTCTGATATGCTGTCCCTG-3', a reverse primer 5'-AAAACAGGGACAGCATAT-CAGAGTTCGCTCTGATATGCTGTCCCTGC-3'. The double stand DNA was inserted into pENTR/ H1/TO vector to generate the pENTR/H1/TO-BclxL siRNA construct using BLOCK-iTTM Inducible H1 RNAi Entry Vector Kit (Invitrogen, Carlsbad, CA). Transfection of pENTR/H1/TO-Bcl-xL siRNA was performed by electroporation using a Gene Pulser II (Bio Rad, Hercule, CA) at 250 V/950 µF, and the transfected cells were allowed to grow at 37 o C for 48 h before gamma ray irradiation.
Immunoblot analysis
Total cell lysates (50 µg of protein) was separated by 10 or 15% SDS-PAGE, transferred to nitrocellulose paper, and analyzed with specific antibodies. Antibodies against Bcl-2, caspase-9 and β-actin were from Santa Cruz Biotechnology (Santa Cruz, CA), antibodies against Bcl-xL, Bad, Bax, Bak, cleaved caspase-3 (Asp175) and poly-(ADPribose) polymerase (PARP) from Cell Signaling Technology (Beverly, MA). cytochrome C release into cytoplasm was analyzed by subcellular fractionation (Ahn et al., 2000) followed by immunoblotting using antibody from BD Biosciences (San Diego, CA). The proteins were visualized by incubation with an enhanced chemiluminescence substrate mixture (Pierce) and then exposed to X-ray film (AGFA Curix RPI). The densities of visualized bands were quantified using a NIH Image J software and relative band densities were expressed as percentages of corresponding control densities.
Real-time quantitative RT-PCR
Real-time quantitative RT-PCR was performed as described previously (Cho et al., 2007) . Total RNA was isolated from the harvested cells using acid guanidinium thiocyanate-phenol chloroform extraction method. First-strand cDNA was synthesized with oligo-dT as primers, using SuperScript FirstStrand Synthesis System according to manufacturer's protocol (Invitrogen, Carlsbad, CA). PCR was performed with specific primers: Bcl-xL; a forward primer 5'-TTGGACAATGGACTGGTTGA-3', a reverse primer 5'-GTAGAGTGGATGGTCAG-TG-3', GAPDH; a forward primer 5'-ACCACAGTC-CATGCCATCAC-3', a reverse primer 5'-TCCACC-ACCCTGTTGCTGTA-3'. Real-time RT-PCR was performed in a 25 µl mixture composed of 200 nM each of forward and reverse primers, and iQTM SYBR Green Supermix (Roche, Basel, Switzerland) using iCyler and iQ software (Bio Rad, Hercules, CA). After 40 cycles of PCR, average threshold cycle (Ct) values for Bcl-xL from the triplicate PCR reactions were normalized against the average Ct values for GADPH from the same cDNA sample.
Data analysis
At least three or more independent experiments were conducted for all the analysis. The nonparametric Mann-Whitney U test was used to analyze mean values, and a P value of ＜ 0.05 was considered statistically significant.
Results
Gαs protected SH-SY5Y neuroblastoma cells from gamma ray-induced apoptosis
To investigate the role of Gα s in gamma rayinduced apoptosis, we used a SH-SY5Y human neuroblastoma cell line, which stably expresses a mutant form of Gαs (GαsQL) that constitutively activates adenylate cycleases (Jang and Juhnn, 2001 ). The expression of mutant Gαs was confirmed again in this study by Western blot analysis of GαsQL expression using antibodies specific for Gαs, HA-tag, or phosphorylated CREB, and by measuring the basal cAMP levels; in the Gα sQL expressing cells cAMP level was increased from 3.4 ± 0.6 pmol/mg protein to 28.5 ± 0.5 pmol/mg protein (P ＜ 0.05) in vector-transfected cells (data not shown). When SH-SY5Y cells were irradiated with varying dose of gamma ray from 1 to 30 Gy, the cell viability decreased and cleavages of caspase-3 and PARP increased in a dose-dependent manner ( Figure 1A ). Gamma ray-irradiation (4 Gy) induced the cleavages of caspase-9, caspase-3, and PARP in SH-SY5Y cells, and the expression of GαsQL decreased the cleavages of caspase-9 (18.5 ± 1.4%, P ＜ 0.05), caspase-3 (23.6 ± 4.4%, P ＜ 0.05) and PARP (28.3 ± 1.8%, P ＜ 0.05), and cytochrome C release (17.3 ± 2.9%, P ＜ 0.05) into cytosol versus vector-transfected cells Figure 1 . Effects of Gαs on gamma ray-induced apoptosis of SH-SY5Y human neuroblastoma cells. (A) Effects of gamma ray irradiation dose on apoptosis of SH-SY5Y cells. SH-SY5Y cells, plated in 96-well plates (5,000 cells/well), were exposed to varying dose of gamma ray (0-30 Gy). Then, the cell viability was assessed by MTT assay and apoptosis was assessed by Western analysis of the cleavages of capspase-3 and PARP 24 h after irradiation. (B, C) Effects of GαsQL on gamma ray-induced apoptosis. At 24 h after gamma ray irradiation (4 Gy), apoptosis was assessed by Western analysis of the cleavages of caspase-9, capspase-3 and PARP (B) in vector (V)-or GαsQL-expressing SH-SY5Y cells. The cytochrome C release into cytosol was analyzed by Western blotting after cytosolic and mitochondrial fractions were prepared by centrifugation. The histograms shows representative FACS analysis data of Annexin V stained cells (C). The blots shown are representative of at least three independent experiments. Histograms represent average and ± SE. And the data are expressed as percentages of corresponding densities of control cells. Asterisks indicate significant difference (P ＜ 0.05 compared with radiation exposed cells, Mann-Whitney U-test). Figure 1B ). Stable Gα sQL expression reduced Annexin V positive cells to 13.6 ± 3.7% from 49.9 ± 1.0% (P ＜ 0.05) in vector transfected control following gamma ray irradiation ( Figure 1C ). This result suggests that Gα s can protect SH-SY5Y neuroblastoma cells from gamma ray-induced apoptosis of SH-SY5Y cells.
h after irradiation (
Gα s inhibited gamma ray-induced apoptosis by restraining down-regulation of Bcl-xL protein in SH-SY5Y neuroblastoma cells
To study the mechanism for Gαs to protect the neuroblastoma cells from gamma ray-induced apoptosis, the effects of Gα s on the expression of Bcl-2 family proteins following gamma ray irradiation was examined. Gamma ray irradiation decreased expression of anti-apoptotic Bcl-xL protein to 59.4 ± 1.8% (P ＜ 0.05) without changing the expression of Bcl-2 protein. The radiation increased the expression of pro-apoptotic Bak Figure 2 . Involvement of Bcl-xL in the protective effects of Gαs against gamma ray-induced apoptosis. (A) Effects of Gαs on gamma ray-induced expression of Bcl-2 family proteins. At 24 h after gamma ray irradiation (4 Gy), SH-SY5Y cells were harvested and analyzed for anti-apoptotic and pro-apoptotic Bcl-2 family proteins by Western blotting. The blots shown are representative of at least three independent experiments. Histograms represent means and ± SE of the relative density of Bcl-xL expressed as percentages of corresponding densities of control cells in the Western blot. Asterisks indicate significant difference (P ＜ 0.05 compared with radiation exposed cells, MannWhitney U-test). (B) Effects of antioxidant on gamma ray-induced apoptosis of SH-SY5Y cells. Cells were pretreated with 100 µM NAC for 30 min and then exposed to gamma ray (4 Gy). Apoptosis was assessed by Western analysis of the cleavages of capspase-3 and PARP, Bcl-xL and Bak 24 h after irradiation. (C) Effects of knockdown of Bcl-xL on the protective effects of Gαs against gamma ray-induced apoptosis. SH-SY5Y cells were transfected with 15 µg of Bcl-xL plasmid (pENTR-Bcl-xL siRNA) of vector control (pENTR-lacZ) by electroporation. At 48 h after transfection, cells were irradiated with gamma ray (4 Gy), and then apoptosis were assessed after 24 h by Western blotting. Data are expressed as percentages of corresponding densities of control cells and the histograms represent mean ± SE. Asterisks indicate significant differences (P ＜ 0.05 compared with radiation exposed cells, Mann-Whitney U-test).
protein to 3.1 ± 0.3-fold (P ＜ 0.05), but decreased the expression of Bax (34.6 ± 1.2%, P ＜ 0.05) and Bad proteins (44.1 ± 1.4%, P ＜ 0.05). The stable expression of Gα sQL restored the gamma ray-induced decrease in Bcl-xL expression to 98.3 ± 1.7% of the un-irradiated control without affecting Bcl-2 expression. In addition, expression of GαsQL increased the basal level of Bak by 1.5 ± 0.2-fold (P ＜ 0.05), but reduced the gamma rayinduced expression of Bak to 1.7 ± 0.1-fold (P ＜ 0.05) of the untreated vector control level. The expression of Gα sQL showed a tendency to increase the basal and gamma ray-induced expression of Bax and Bad proteins in comparison to vector-transfected control (Figure 2A ). Because ionizing radiation induces production of ROS, the effect of ROS on the gamma ray induced apoptosis was analyzed. Pretreatment with an antioxidant Nacetyl-L-cysteine (NAC) effectively blocked the gamma ray-induced decrease in Bcl-xL expression and the increase in Bak expression ( Figure  2B ). NAC treatment also significantly reduced gamma ray-induced cleavages of caspase-3 and PARP, suggesting that ROS mediates the apoptotic cell death induced by the gamma ray irradiation.
Next, to confirm the role of Bcl-xL in the protective effect of Gαs against gamma ray-induced apoptosis, the expression of Bcl-xL was knockdown by siRNA method. The transfection of Bcl-xL siRNA decreased the basal expression of Bcl-xL in both the GαsQL expressing cells (65.5 ± 1.3%, P ＜ 0.05) and vector-transfected cells (58.5 ± 1.4%, P ＜ 0.05), and it also augmented gamma ray-induced decrease in Bcl-xL expression in both the GαsQL expressing cells (36.4 ± 3.2%, P ＜ 0.05) and vector-transfected cells (34.9 ± 1.5%, P ＜ 0.05). Transfection of Bcl-xL siRNA increased gamma ray-induced caspase-3 cleavage from 34.7 ± 4.0% to 105.6 ± 28.1% (P ＜ 0.05) and PARP from 23.6 ± 3.4% to 117.7 ± 11.7% (P ＜ 0.05) in Gα sQL expressing cells versus gamma ray irradiated vector-transfected control ( Figure 2C ). This result suggests that restraining down-regulation of Bcl-xL expression might be one mechanism for Gα s to inhibit apoptosis induced by gamma ray irradiation in SH-SY5Y neuroblastoma cells.
Gα s restrained gamma ray-induced Bcl-xL down-regulation by inhibiting the degradation of both Bcl-xL protein and mRNA
To investigate the mechanism whereby Gαs restrained the gamma ray-induced Bcl-xL down-regulation, we first examined the degradation rate of Bcl-xL protein. The degradation rate of Bcl-xL protein in Gα sQL expressing cells was significantly slower than that in vector transfected cells, so the half-life of Bcl-xL protein after cycloheximide treatment increased to approximately 14.4 ± 0.2 h (P ＜ 0.05) in Gα s expressing cells from 8.0 ± 0.2 h in vector transfected cells ( Figure 3A) . Next, the effect of Gα s expression on the Bcl-xL mRNA level was examined. Gamma ray irradiation removed most of Bcl-xL mRNA, but the expression of GαsQL preserved most of Bcl-xL mRNA after 24 h following the irradiation. This result was confirmed by quantitative real time RT-PCR analysis, which showed that gamma ray irradiation decreased Bcl-xL mRNA level to 14.4 ± 6.8% (P ＜ 0.05) of the untreated vector-transfected control, and that GαsQL expression increased the basal Bcl-xL mRNA level to 116.6 ± 0.6% (P ＜ 0.05), and preserved almost intact Bcl-xL mRNA level (100.1 ± 10.2%, P ＜ 0.05) following gamma ray irradiation ( Figure 3B) .
Then, to probe the mechanism of increased Bcl-xL mRNA levels, we examined the effects of Gαs on the degradation of Bcl-xL mRNA after inhibition of transcription by treatment with actinomycin D. The degradation rate of Bcl-xL mRNA in GαsQL expressing cells was significantly slower than that in vector transfected cells, so the half-life of Bcl-xL mRNA increased to approximately 5.5 ± 0.1 h (P ＜ 0.05) in Gα s-expressing cells from 1.1 ± 0.3 h in vector transfected cells ( Figure 3C ). Actinomycin D treatment caused a rapid decrease in Bcl-xL mRNA level to 38.9 ± 4.9% (P ＜ 0.05) without gamma ray irradiation, and to 12.0 ± 2.4% (P ＜ 0.05) of the vector-transfected control 2 h after irradiation. However, GαsQL expression maintained Bcl-xL mRNA level to 87.6 ± 1.9% (P ＜ 0.05) of the untreated vector-transfected control after Acinomycin D treatment, and it also maintained Bcl-xL mRNA to 83.1 ± 1.9% (P ＜ 0.05) following irradiation ( Figure 3D ). This result indicates that Gα s restrains gamma ray-induced BclxL down-regulation by slowing down degradation of both Bcl-xL mRNA and protein.
GPCR ligands modulated the gamma ray-induced apoptosis of SH-SY5Y neuroblastoma cells
Gαs was found to protect gamma ray-induced apoptosis of SH-SY5Y neuroblastoma cells by restraining down-regualtion of Bcl-xL, so, we examined whether PGE2, of which receptor activates Gαs to stimulate adenylate cyclases, can also protects gamma ray-induced apoptosis. Pretreatment with PGE2 reduced gamma ray-induced caspase-3 cleavage to 28.3 ± 9.4% (P ＜ 0.05) and PARP cleavage to 33.7 ± 6.2% (P ＜ 0.05) of untreated control ( Figure 4A) . Then, the subtype of Effects of PGE2 on gamma ray-induced apoptosis. SH-SY5Y cells were pretreated with 10 µM PGE2, AH6809, AH23848 and SC19220 for 30 min before gamma ray exposure (4 Gy) and then cells were harvested after 24 h. (B) Effects of adenosine A1 agonists on gamma ray-induced apoptosis. SH-SY5Y cells were pretreated with 10 µM R-PIA or CCPA for 30 min before gamma ray irradiation (4 Gy) for 24 h. Apoptosis was assessed by Western analysis for cleavages of caspase-3 and PARP in SH-SY5Y cells, and the blots shown are representative of at least three independent experiments. Data are expressed as percentages of corresponding densities for gamma ray-irradiated cells and the histograms represent mean ± SE. Asterisks indicate significant differences (P ＜ 0.05 versus control cells, Mann-Whitney U-test).
PGE2 receptors involved in anti-apoptotic effects of PGE2 was examined. Co-treatment of PGE2 together with AH6809, an EP1/EP2 mixed prostanoid receptor antagonist increased gamma rayinduced caspase-3 cleavage to 251.6 ± 35.1% (P ＜ 0.05), and PARP cleavage to 205.6 ± 5.3% (P ＜ 0.05), respectively in SH-SY5Y cells. Similarly, co-treatment of PGE2 together with AH23848, an EP4 prostanoid antagonist, increased gamma ray-induced caspase-3 cleavage to 233.0 ± 7.8% (P ＜ 0.05), and PARP cleavage to 192.1 ± 13.9% (P ＜ 0.05), respectively. On the other hand, co-treatment of PGE2 together with SC19220, an antagonist specific for EP1 prostanoid receptor that activates inhibitory G proteins (Gα i2) to inhibit adenylate cyclase, decreased the gamma ray-induced caspase-3 cleavage to 10.5 ± 4.9% (P ＜ 0.05) and PARP cleavage to 4.6 ± 6.0% (P ＜ 0.05) in PGE2-treated cells ( Figure 4A ). Furthermore, treatment of SH-SY5Y cells with R-PIA and CCPA, agonists for adenosine A1 receptor that also activates Gα i2 to inhibit adenylate cyclases, increased gamma ray-induced apoptosis. Pretreatment with R-PIA augmented caspase-3 cleavage to 203.9 ± 13.0% (P ＜ 0.05) and PARP cleavage to 169.6 ± 4.4% (P ＜ 0.05), respectively, and pretreatment with CCPA also augmented caspase-3 cleavage to 204.5 ± 14.4% (P ＜ 0.05), and PARP cleavage to 181.6 ± 6.7% (P ＜ 0.05) ( Figure 4B ). This result indicates that GPCR agonists and antagonist coupled to Gα s/ Gα i-cAMP signaling pathway can regulate gamma ray-induced apoptosis.
Discussion
This study was performed to investigate the molecular mechanism for Gαs-cAMP signaling pathways to inhibit radiation-induced apoptosis, and we found that Gαs inhibits gamma ray-induced apoptosis by restraining down-regulation of Bcl-xL in SH-SY5Y human neuroblastoma cells. This finding is supported by the result that stable expression of constitutively active Gα sQL inhibited gamma ray-induced apoptosis, which was assessed by cleavage of caspase-9, caspase-3 and PARP, cytochrome C release, and FACS analysis of Annexin V-stained cells. Second, expression of Gα sQL preserved Bcl-xL level by reducing the degradation rate of both Bcl-xL protein and mRNA following gamma ray irradiation. Third, blocking of Bcl-xL expression by treatment with Bcl-xL siRNA abolished the inhibitory effects of Gαs on gamma ray-induced apoptosis. Finally, pretreatment with PGE2 that activates Gαs also inhibited gamma ray-induced apoptosis via Gαs-coupled receptor subtype dependent pathways.
Ionizing radiation induces DNA damages to cause cell death by various mechanisms including apoptosis. During radiation-induced apoptosis, a variety of signaling pathways are activated to regulate the activity of apoptosis-related molecules. Ionizing radiation has been reported to increase in the activity of pro-apoptotic Bax in contrast to decrease in that of anti-apoptotic Bcl-2 family including Bcl-2 and Bcl-xL (Findley et al., 1997) . cAMP signaling has been known to exert a protective effect against radiation-induced cell death for a long time (Lehnert, 1975) , and has been reported to inhibit radiation-induced apoptosis by up-regulation of Bcl-2 expression which prevent activation of capase-9 by inhibiting the release of cytochrome C from mitochondria into the cytosol (Srivastava et al., 1998) . The inhibition of PKA was reported to have a cooperative anti-tumor effect with radiotherapy and to cause inactivation of Bcl-2 which eventually leads to induction of apoptosis (Tortora and Ciardiello, 2002) . The promoter of Bcl-2 gene contains cyclic AMP response element (CRE) that enables cAMP signaling pathway to up-regulate the Bcl-2 gene expression by CRE binding proteins (CREB) (Wilson et al., 1996) . However, the effects of cAMP signaling system on the expression of Bcl-xL, another antiapoptotic Bcl-2 family protein, following exposure to ionizing radiation has not been reported yet, and in this study we shows that Gαs-cAMP signaling system can protect radiation-induced apoptosis by up-regulating the expression of Bcl-xL, indicating another mechanism for cAMP signaling pathway to protect radiation-induced apoptosis. This finding agrees well with the report that treatment with a cAMP analogue, sp-5,6-DCl-BIMPS, was found to suppress apoptosis by restraining the Bcl-xL downregulation in CD34(+) cells (Negrotto et al., 2006) . The alpha subunit of stimulatory G protein (Gα s) activates adenylate cyclase to increase cellular cAMP, which in turn activates signaling pathway that has been reported to regulate apoptosis in a variety of cell types and neurons including SH-SY5Y human neuroblastoma cells. However, cAMP signaling system has been reported to stimulate apoptosis in some type of cells, suggesting that cAMP signaling system inhibits or stimulates apoptosis depending on the cell types and on the nature of apoptosis-triggering agents.
In humans, Bcl-x encodes two distinct species of mRNA designated Bcl-xL and Bcl-xS. The protein product of the longer transcript, Bcl-xL can inhibit apoptosis in tumor cell lines but, the smaller transcript, Bcl-xS can act as a dominant facilitator of cell death (Boise et al., 1993) . The anti-apoptotic Bcl-2 members including Bcl-xL prevent mitochondrial protein release by interacting with and inhibiting both Bak/Bax and BH3-only proteins. When Bad heterodimerizes with Bcl-xL in mammalian cells, it releases Bax from Bcl-xL complex, which results in the cytochrome C release to promote cell death (Oltvai et al., 1993; Yang et al., 1995 Yang et al., , 2006 . The relative levels and competing dimerization between Bcl-2 family members can indirectly prevent the activation of executioner caspases by controlling cytochrome C efflux from mitochondria. In particular, Bax interacts with mitochondrial membrane allowing cytochrome c release, whereas Bcl-2 and Bcl-xL act in the opposite way, interfering with the activation of Bax (Yang et al., 1995) .
Interestingly, Bcl-xL but not Bcl-xS is highly expressed in neuroblastoma cell lines. Moreover, Bcl-xL contributes to pleiotropic drug resistance in neuroblastoma tumors by inhibiting chemotherapyinduced apoptosis, and Bcl-xL over-expression protects radiation-induced apoptosis in many cancer cell lines (Dole et al., 1995; Taylor et al., 1999) . These reports indirectly support our finding that Gα s-cAMP signaling system can exert a protective effect against ionizing radiation-induced apoptosis by inducing Bcl-xL expression.
In a study to probe the mechanism for Gαs to restrain Bcl-xL down-regulation, we found that Gαs slows down the degradation of both Bcl-xL mRNA and protein following gamma ray irradiation. Similar restraining of Bcl-xL down-regulation by cAMP signaling system was reported in serum deprivation-induced apoptosis in CD34+-derived megakaryocytes (Negrotto et al., 2006) . Gα s was found to restrain the Bcl-xL mRNA down-regulation after blocking transcription by actinomycin treatment, and to slow down the degradation of Bcl-xL mRNA, suggesting that Gα s increase stability of Bcl-xL mRNA to restrain Bcl-xL down-regulation. However, the mechanism for Gα s to increase the stability of Bcl-xL mRNA needs to be elucidated. Furthermore, the effects of Gαs on the transcription of Bcl-xL cannot be excluded because more mRNA was maintained in the cells that were not treated with actinomycin D, after gamma ray irradiation. In addition to stabilization of Bcl-xL mRNA, Gαs signaling system was found to slow down the degradation of Bcl-xL protein, which also can contribute to maintain a higher protein level required for anti-apoptotic effect of Gα s-cAMP system. Thus, this study shows that Gα s-cAMP signaling system protects SH-SY5Y neuroblastoma cells by slowing down Bcl-xL mRNA and protein following gamma ray-irradiation. Moreover, Gα s was found to represse ionizing radiation-induced up-regulation of Bak in SH-SY5Y human neuroblastoma cells, which also favors cell survival (Choi et al., 2006) , indicating Gαs-cAMP signaling system protects cells against radiation-induced apoptosis by affecting multiple pro-apoptotic and anti-apoptotic Bcl-2 family proteins.
This study also shows that radiation-induced apoptosis can be modulated by the ligands for GPCR that activates Gα s or Gα i to regulate adenylate cyclase activity and thus cAMP levels. This finding is supported by the result that treatment with PGE2 that binds to Gα s-coupled receptor protected gamma ray-induced apoptosis in SH-SY5Y cells. PGE2 binds to four different receptor subtypes termed EP1, EP2, EP3 and EP4, among which EP2 and EP4 receptors couple to a Gαs (Hata and Breyer, 2004) . The protective effect of Gαs against gamma ray-induced apoptosis was abolished by treatment with specific EP2/4R antagonist such as AH6809 and AH23848, but treatment with an antagonist of EP1 receptor that couples to Gαi to inhibit adenylate cyclases decreased the apoptosis. In the same vein, treatment with R-PIA and CCPA, agonists for adenosine A1 receptor that also activate Gα i to inhibit adenylate cyclases, augmented ionizing radiationinduced apoptosis of the SH-SY5Y neuroblastoma cells. Adenosine receptors are major targets of caffeine, and there is growing evidence that they could also be promising therapeutic targets in a wide range of conditions, including cancer (Jacobson and Gao, 2006) . Our finding agrees well with the reports that PGE2 protects against apoptosis of human colon cancer cells (Sheng et al., 1998) , and thus EP receptors have been identified as potential targets for treatment and prevention of colorectal cancer. The anti-apoptotic effect of PGE2 and pro-apoptotic effect of adenosine A1 can result from the modulation of Gα s/ Gαi-cAMP signaling pathway that regulates expression of various apoptosis-related molecules including Bcl-xL. This finding suggests that the therapeutic efficiency of cancer radiotherapy can be improved by co-treatment with specific GPCR ligands that inhibits Gαs-cAMP signaling system to reduce the resistance to radiation-induced apoptosis.
From this study, it is concluded that Gα s can protect SH-SY5Y neuroblastoma cells from gamma ray-induced apoptosis partly by restraining Bcl-xL down-regulation, which can be modulated by the ligands of various receptors that couple to Gα s or Gαi. This finding provides a better understanding how Gα s signaling pathways modulate gamma ray-induced apoptosis, and an important clinical implications that the efficiency of radiation therapy against cancer cells could be improved by modulation of Gα s/Gαi-cAMP signaling system with agonists or antagonists for cancer-cell specifically expressed GPCR.
